Another case of intracranial pathology was observed in an earlier clinical trial for metachromatic leukodystrophy (MLD), a lysosomal disease caused by a defect in the arylsulfatase A (ARSA) gene. The gene discussed is ARSA; the disease is Lysosomal disease.